Common heart pill tested as secret weapon against ovarian cancer
NCT ID NCT04457089
Summary
This small, early-stage study tested whether adding a common cholesterol-lowering drug (simvastatin) to standard chemotherapy could help slow the progression of recurrent ovarian cancer. It involved 18 women whose cancer had returned but was still sensitive to platinum-based drugs. The main goal was to see if patients could safely take the drug combination and if it showed any signs of delaying the cancer's return.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT OVARIAN CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cedars Sinai Medical Center
Los Angeles, California, 90048, United States
Conditions
Explore the condition pages connected to this study.